Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

First Helium: a Canadian company exploring and developing two premier helium projects

When you think of Alberta, Helium companies may not be top of mind. But look no further, First Helium has identified many follow-up drill locations and acquired a well operating infrastructure system which will help expand future exploration programs. Consisting of t...
Brieanna McCutcheon | February 27, 2023 |

Favourable Ruling for Emerita Resources on the Aznalcollar Zinc-Lead-Silver Project in Spain

Full size / The Aznalcóllar open-pit near Seville in southern Spain ( source ). Good news for Emerita Resources Corp. as the company today announced favourable ruling on the Aznalcóllar Zinc-Lead-Silver Project appeal. This is making headlines in the news at...
Stephan Bogner | October 4, 2019 |

Why This Small-Cap Miner Could Be a 'Once-in-a-Generation Wealth Builder'

I had been familiar with the story and potential of uber micro-cap (a valuation of little more than C$3 million or so for a LONG time!) Omineca Mining and Metals Ltd.'s (OMM:TSX.V; OMMSF:OTCMKTS) for years. But as gold was beginning to percolate and other necessa...
Streetwise Reports | June 24, 2020 |

Teekay Offshore Shares Spike 30% Higher on Brookfield Merger Agreement

Teekay Offshore Partners shares are trading more than 30% higher today on news that Brookfield Business Partners will be purchasing all un-owned common units of the firm for $1.55 per share. This morning Hamilton, Bermuda based Teekay Offshore Partners L.P. (TOO:NYSE...
Streetwise Reports | October 2, 2019 |

PDAC 2021 Day 4: Predictions of the Markets, Commodities, and Resources

PDAC 2021 – the preeminent event for the world’s mineral exploration and mining industry, and first-ever to be held virtually – wraps up today with capital markets’ proverbial 'fortune tellers' looking into their crystal balls to predict what...
Stockhouse Media | March 10, 2021 |

Buzz on the Bullboards: Markets struggle in Q1 2023

Despite a solid start to the year, markets on Bay Street and Wall Street have struggled since fresh calendars went up. This week, Canada’s top banks have been pointing to economic pain ahead with higher loan loss provisions and a fall in quarterly prof...
Jonathon Brown | March 2, 2023 |

New Data Could Drive Use of Pancreatic Cancer Early Detection Test

The recent results and their implications are provided in an H.C. Wainwright & Co. report. In an Oct. 25 research note, H.C. Wainwright & Co. analyst Yi Chen reported that newly compiled data support the clinical utility of Interpace Diagnostics Group Inc.'s (IDXG:NA...
Streetwise Reports | October 30, 2019 |

Protagonist Therapeutics Shares Trade Up 70% on Phase 2 Transfusion Trial Results

Newark, Calif.-based Protagonist Therapeutics' shares traded 70% higher today after the firm reported preliminary Phase 2 results for Hepcidin Mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia. Clinical-stage biopharmaceutical company Protago...
Streetwise Reports | December 5, 2019 |

Neurotrope's Shares Double on Phase 2 Alzheimer's Study Data and $2.7 Million NIH Grant

Neurotrope's shares traded higher today after reporting results from its Phase 2 "203" clinical trial of Byrostatin-1 for treatment of moderately severe to severe Alzheimer's patients. The firm has also been awarded a $2.7 million grant from the National Institutes of Health t...
Streetwise Reports | January 23, 2020 |

Have the Stock Bulls Really Sealed the Short-Term Crack in the Dam?

Stocks again made a new intraday 2020 high yesterday, but the bulls were stopped just a point shy of the 3395 mark. Has yesterday’s increase invalidated our reasons to be cautious and take profits off the table? In other words, can we expect the bulls to push t...
Monica Kingsley | February 20, 2020 |
1 2 3 4 5 6 7 8 9 10 ...